Ameriprise Financial Inc. raised its position in shares of Clorox Company (The) (NYSE:CLX) by 24.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,341,272 shares of the company’s stock after buying an additional 265,200 shares during the period. Ameriprise Financial Inc. owned about 1.04% of Clorox Company (The) worth $178,433,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of Clorox Company (The) by 4.8% during the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock worth $1,909,829,000 after buying an additional 649,766 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Clorox Company (The) by 1,402.2% during the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock worth $1,400,912,000 after buying an additional 9,698,542 shares in the last quarter. State Street Corp increased its holdings in shares of Clorox Company (The) by 2.2% during the first quarter. State Street Corp now owns 7,648,999 shares of the company’s stock worth $1,031,304,000 after buying an additional 167,689 shares in the last quarter. Wells Fargo & Company MN increased its holdings in shares of Clorox Company (The) by 5.3% during the second quarter. Wells Fargo & Company MN now owns 4,412,600 shares of the company’s stock worth $587,934,000 after buying an additional 221,168 shares in the last quarter. Finally, Parnassus Investments CA acquired a new stake in shares of Clorox Company (The) during the first quarter worth approximately $434,255,000. 71.28% of the stock is owned by institutional investors.

In related news, COO Dawn C. Willoughby sold 2,158 shares of the stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total value of $297,804.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP James E. Foster sold 9,861 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the completion of the transaction, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The disclosure for this sale can be found here. In the last three months, insiders sold 21,242 shares of company stock valued at $2,944,449. 0.74% of the stock is owned by insiders.

Several research firms have recently weighed in on CLX. Jefferies Group LLC reaffirmed a “hold” rating and set a $137.00 price objective (up previously from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. BMO Capital Markets reaffirmed an “outperform” rating on shares of Clorox Company (The) in a report on Tuesday. Royal Bank Of Canada reaffirmed a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a report on Wednesday, August 2nd. BidaskClub raised shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st. Finally, Zacks Investment Research lowered shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. Clorox Company (The) has a consensus rating of “Hold” and a consensus target price of $129.05.

Shares of Clorox Company (CLX) traded down 0.085% during mid-day trading on Friday, hitting $134.625. 168,344 shares of the company were exchanged. The company’s 50-day moving average price is $135.86 and its 200-day moving average price is $135.24. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76. The firm has a market capitalization of $17.38 billion, a P/E ratio of 25.234 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm’s revenue was up 2.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.30 EPS. Equities research analysts predict that Clorox Company will post $5.66 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 2.49%. The ex-dividend date is Tuesday, October 24th. Clorox Company (The)’s payout ratio is 63.04%.

TRADEMARK VIOLATION NOTICE: “Clorox Company (The) (CLX) Stake Increased by Ameriprise Financial Inc.” was reported by Daily Political and is the property of of Daily Political. If you are accessing this article on another domain, it was stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this article can be read at https://www.dailypolitical.com/2017/09/15/clorox-company-the-clx-stake-increased-by-ameriprise-financial-inc.html.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.